Related Experiment Video
Updated: Jun 1, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Four-month-old infant with chronic granulomatous disease and invasive aspergillosis with bone involvement
Héctor Gómez-Tello1, Estefany Graciela Mamani-Velásquez2, Ana Karen Gómez-Gutiérrez3
1Departamento de Alergias, Hospital para el Niño Poblano, Puebla, México.
Insights
Invasive aspergillosis is rare in infants with chronic granulomatous disease (CGD). This case highlights aggressive treatment needs for invasive aspergillosis in infants with CGD, even in challenging environments.
Area of Science:
- Immunology
- Pediatrics
- Infectious Diseases
Background:
- Chronic granulomatous disease (CGD) is an inborn error of immunity linked to a high incidence of invasive aspergillosis.
- Invasive aspergillosis typically affects adolescents with CGD, with rare occurrences before age one.
Purpose of the Study:
- To report a rare case of invasive aspergillosis in a four-month-old infant with chronic granulomatous disease.
- To emphasize the potential for invasive aspergillosis in infants with CGD and the need for aggressive management.
Main Methods:
- Case report of a four-month-old male infant diagnosed with chronic granulomatous disease and invasive aspergillosis.
- Diagnostic procedures included computed tomography scans, isolation of Aspergillus fumigatus, dihydrorhodamine test, and CYBB gene sequencing.
- Treatment involved broad-spectrum antibiotics and voriconazole.
Main Results:
- The infant presented with axillary abscess, pneumonia, and pulmonary nodules, initially suspected as child abuse.
- Aspergillus fumigatus was identified in abscess pus, confirming invasive aspergillosis.
- The patient had a CYBB gene mutation (c.80_83del/Y), with the mother as a carrier.
- Despite treatment, the infant experienced refractory invasive aspergillosis and died at 12 months of age.
Conclusions:
- Environmental factors significantly influence infectious agent exposure in CGD patients.
- Invasive aspergillosis can manifest in infants with CGD and requires prompt, aggressive treatment.
- This case underscores the importance of early diagnosis and intervention for invasive aspergillosis in young children with CGD.
Abstract:
Chronic granulomatous disease is the inborn error of immunity with the highest frequency of invasive aspergillosis. In this context, invasive aspergillosis is frequent in adolescence, with rare cases before one year of age. We present a case of chronic granulomatous disease and invasive aspergillosis in a four-month-old infant. The patient was a male infant living in jail with his hypothyroid mother. He presented with a tumor in the left axillary region when he was four months old, and the chest X-ray suggested rib fractures. The patient was hospitalized on suspicion of child abuse. The chest computed tomography scan showed axillary abscess, rib osteolysis, pneumonia, and pulmonary nodules. He was treated with broad-spectrum antibiotics, and then he was discharged. Four months later, he was readmitted with fever and extension of the purulent abscess to the left scapular region; a computed tomography scan showed worsening images. Aspergillus fumigatus was isolated from the abscess pus, leading to an invasive aspergillosis diagnosis. The patient was treated with voriconazole for 28 days, and then he was discharged. The chronic granulomatous disease was diagnosed by the dihydrorhodamine test. The mutated gene causing the inborn error of immunity was CYBB with the variant c.80_83del/Y; the mother was the carrier (c.80_83del/WT). At 12 months of age, the patient was readmitted for invasive aspergillosis, refractory to treatment, and died. This exceptional case teaches us how environmental conditions determine exposure to infectious agents in chronic granulomatous disease patients. Also, it illustrates that invasive aspergillosis can develope in infants with this pathology and should be treated aggressively.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

